Abstract: The present invention provides oral solutions containing sotalol hydrochloride which advantageously avoid swallowing while providing with improved stability. The present invention also relates to methods of using the oral solutions for treatment of diseases and disorders, such as delay in reoccurrence of atrial fibrillation/atrial flutter and/or ventricular arrhythmias.

Abstract: An uninterruptible power supply to be connected between an AC line and a load has a battery system, an inverter, a transformer, and a controller. The battery system stores battery power. The inverter is operatively connected to the battery system. The transformer comprises a primary winding adapted to be connected to the AC line, a load winding adapted to be connected to the load, and an inverter winding operatively connected to the inverter. The controller controls the inverter to operate in a first mode in which the inverter supplies power to the battery system, a second mode in which the inverter supplies power to the load winding using battery power stored in the battery system, and a third mode in which the inverter supplies power to the primary winding using battery power stored in the battery system.

Abstract: An energy recovery ventilator (ERV) monitoring and reporting system and a method of monitoring and reporting information on an ERV. In one embodiment, the system includes: (1) a processor configured to carry out a plurality of monitoring and reporting functions on the ERV based on a model, and types and locations of sensors, of the ERV, (2) a memory coupled to the processor and configured to store data gathered from the sensors and (3) a commissioning database associated with the memory and configured to contain commissioning data regarding the model of the ERV.

Abstract: Various methods and systems are provided for regulating air flow through a two-stage turbocharger. In one embodiment, a method for an engine comprises, in response to a transient engine operating event, adjusting a provided amount of exhaust gas recirculation provided to an intake of the engine based on at least one of desired intake oxygen, one or more turbocharger conditions of a turbocharger, or a magnitude of the transient engine operating event.

Abstract: An uninterruptible power supply for supply electrical power to a load, comprises a connection to a primary source for supplying primary power, a battery system for storing battery power, an inverter, and a controller. The controller controls the inverter to operate in a first mode, a second mode, and in a third mode. In the first mode, power is supplied to the primary load and the battery system based on primary power. In the second mode, power is supplied to the primary load based on battery power. In the third mode, power is supplied to the primary source based on battery power.

Abstract: A method for controlling an engine includes the steps of, in response to a transient operating event, determining a first amount of exhaust gas recirculation (EGR) that if provided to an intake of the engine would avoid turbocharger compressor surge in a turbocharger, determining a second amount of EGR that if provided to the intake would avoid turbocharger compressor choke in the turbocharger, and determining a third amount of EGR that if provided to the intake would avoid engine smoking, and adjusting EGR provided to the intake of the engine in accordance with the determined first, second, and third amounts.

Abstract: The invention provides a method of inhibiting the effects of platelet activating factor (PAF). For instance, a disease or condition mediated by PAF (particularly inflammation) can be treated or platelet aggregation can be inhibited. The invention also provides a method of inhibiting the production and/or release of interleukin 8 (IL-8) by cells. The effects of PAF and the production and/or release of IL-8 are inhibited according to the invention by a compound of the formula: wherein R1 and R2 are defined in the application, or a physiologically-acceptable salt thereof. The invention also provides pharmaceutical compositions comprising these compounds.

Abstract: The invention provides a method of inhibiting the effects of platelet activating factor (PAF). For instance, a disease or condition mediated by PAF (particularly inflammation) can be treated or platelet aggregation can be inhibited. The invention also provides a method of inhibiting the production and/or release of interleukin 8 (IL-8) by cells. The effects of PAF and the production and/or release of IL-8 are inhibited according to the invention by a compound of the formula: wherein R1 and R2 are defined in the application, or a physiologically-acceptable salt thereof. The invention also provides pharmaceutical compositions comprising these compounds.

Abstract: A method of determining fuel limits for an engine includes measuring an actual fuel value for the engine and creating a plurality of engine speed points. The method further includes calculating respective static fuel limit points for each of the engine speed points utilizing the actual fuel value. The static fuel limit points define and limit a rated power of the engine.

Abstract: The invention provides compositions that increase the mobilization, homing, expansion, and/or differentiation of stem cells and methods of using the same for the treatment of mammals.

Abstract: The invention provides a method of inhibiting the effects of platelet activating factor (PAF). For instance, a disease or condition mediated by PAF (particularly inflammation) can be treated or platelet aggregation can be inhibited. The invention also provides a method of inhibiting the production and/or release of interleukin 8 (IL-8) by cells. The effects of PAF and the production and/or release of IL-8 are inhibited according to the invention by a compound of the formula: wherein R1 and R2 are defined in the application, or a physiologically-acceptable salt thereof. The invention also provides pharmaceutical compositions comprising these compounds.

Abstract: Various methods and systems are provided for adjusting a flow of exhaust gas in an exhaust gas recirculation system. In one embodiment, a method for an engine comprises controlling a flow of exhaust gas through an exhaust gas recirculation system of an engine system based on a choke level of a turbocharger. For example, the flow of exhaust gas in the exhaust gas recirculation system may be reduced to within a threshold of a choke level of the turbocharger, in response to an ambient condition.

Abstract: Various methods and systems are provided for determining a surge level of a compressor. In one embodiment, a method for an engine comprises updating a stored estimate of a surge level of a compressor responsive to detection of a surge event.

Abstract: Various methods and systems are provided for engine operation with a degraded turbocharger. In one embodiment, a method for an engine comprises reducing mass flow through a first turbocharger while continuing engine operation and adjusting operation of a second turbocharger in response to detected degradation of the first turbocharger.

Abstract: Various methods and systems are provided for lowering exhaust gas temperature. In one embodiment, a method comprises increasing an air-to-fuel ratio of an engine in response to an exhaust gas temperature exceeding a threshold temperature value to lower the exhaust gas temperature to a temperature below the threshold temperature value.

Abstract: A method for fabricating a grid-stiffened panel which incorporates a network of fluid channels and passageways into the ribs and face sheet is described. The method is comprised of a base tooling assembly, an expansion tooling assembly, a composite prepreg, plugs, a face sheet and a network of valves and pumps, wherein the prepreg is draped over said expansion tooling and assembled with the base tooling assembly to form a rib structure. Channel plugs are placed therein such that gaps between adjacent expansion tooling blocks are filled, and the entire rib structure assembly is autoclaved. The face sheet may be comprised of a plurality of layers, whereby channels are machined into the lower layer(s). The upper layer(s) are bonded to the lower layer(s) to seal the channels, and said face sheet is bonded to the rib structure.

Abstract: Various methods and systems are provided for regulating air flow through a two-stage turbocharger. In one embodiment, a method for an engine comprises, in response to a transient engine operating event, adjusting a provided amount of exhaust gas recirculation provided to an intake of the engine based on at least one of desired intake oxygen, one or more turbocharger conditions of a turbocharger, or a magnitude of the transient engine operating event.

Abstract: Various methods and systems are provided for controlling air flow in a two-stage turbocharger. In one example, an engine method comprises adjusting one or more exhaust gas recirculation valves to maintain a first turbocharger within a first air flow range, and adjusting a turbocharger bypass valve to maintain a second turbocharger within a second air flow range.

Abstract: The invention provides a method of inhibiting the effects of platelet activating factor (PAF). For instance, a disease or condition mediated by PAF (particularly inflammation) can be treated or platelet aggregation can be inhibited. The invention also provides a method of inhibiting the production and/or release of interleukin 8 (IL-8) by cells. The effects of PAF and the production and/or release of IL-8 are inhibited according to the invention by a compound of the formula: wherein R1 and R2 are defined in the application, or a physiologically-acceptable salt thereof. The invention also provides pharmaceutical compositions comprising these compounds.

Abstract: A controller for an HVAC system, a compute-usable medium and an ERV are disclosed. In one embodiment, the controller includes: (1) an input terminal configured to receive feedback data from a first operating unit of the HVAC system, (2) an operation monitor configured to determine if the feedback data corresponds to a predetermined condition for the first operating unit and (3) a system director configured to operate a second operating unit of the HVAC system at a predetermined operating value corresponding to the predetermined condition and a number of occurrences of predetermined conditions associated with the first operating unit.